{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
US Approved Rx
(2000)
First approved in 1990
Source:
BLA103930
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2000)
First approved in 1990
Source:
BLA103930
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2000)
First approved in 1990
Source:
BLA103930
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:lerapolturev [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04429295: Phase 3 Interventional Completed Pertussis Immunisation
(2020)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE